Literature DB >> 22221838

A seroepidemiological study of pandemic A/H1N1(2009) influenza in a rural population of Mali.

O A Koita1, L Sangare, B Poudiougou, B Aboubacar, Y Samake, T Coulibaly, P Pronyk, N Salez, A Kieffer, L Ninove, A Flahault, X de Lamballerie.   

Abstract

The swine-origin H1N1 influenza A virus (pH1N1(2009)) started to circulate worldwide in 2009, and cases were notified in a number of sub-Saharan African countries. However, no epidemiological data allowing estimation of the epidemic burden were available in this region, preventing comprehensive comparisons with other parts of the world. The CoPanFlu-Mali programme studied a cohort of 202 individuals living in the rural commune of Dioro (southern central Mali). Pre-pandemic and post-pandemic paired sera (sampled in 2006 and April 2010, respectively) were tested by the haemagglutination inhibition (HI) method. Different estimates of pH1N1(2009) infection during the 2009 first epidemic wave were used (increased prevalence of HI titre of ≥1/40 or ≥1/80, seroconversions) and provided convergent attack rate values (12.4-14.9%), the highest values being observed in the 0-19-year age group (16.0-18.4%). In all age groups, pre-pandemic HI titres of ≥1/40 were associated with complete absence of seroconversion; and geometric mean titres were <15 in individuals who seroconverted and >20 in others. Important variations in seroconversion rate existed among the different villages investigated. Despite limitations resulting from the size and composition of the sample analysed, this study provides strong evidence that the impact of the pH1N1(2009) first wave was more important than previously believed, and that the determinants of the epidemic spread in sub-Saharan populations were quite different from those observed in developed countries.
© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22221838     DOI: 10.1111/j.1469-0691.2011.03725.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  10 in total

1.  Systematic Review of Important Viral Diseases in Africa in Light of the 'One Health' Concept.

Authors:  Ravendra P Chauhan; Zelalem G Dessie; Ayman Noreddin; Mohamed E El Zowalaty
Journal:  Pathogens       Date:  2020-04-20

2.  Integrative study of pandemic A/H1N1 influenza infections: design and methods of the CoPanFlu-France cohort.

Authors:  Nathanael Lapidus; Xavier de Lamballerie; Nicolas Salez; Michel Setbon; Pascal Ferrari; Rosemary M Delabre; Marie-Lise Gougeon; Frédéric Vely; Marianne Leruez-Ville; Laurent Andreoletti; Simon Cauchemez; Pierre-Yves Boëlle; Eric Vivier; Laurent Abel; Michaël Schwarzinger; Michèle Legeas; Pierre Le Cann; Antoine Flahault; Fabrice Carrat
Journal:  BMC Public Health       Date:  2012-06-07       Impact factor: 3.295

Review 3.  Cross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine design.

Authors:  Anne S De Groot; Lenny Moise; Rui Liu; Andres H Gutierrez; Frances Terry; Ousmane A Koita; Ted M Ross; William Martin
Journal:  Hum Vaccin Immunother       Date:  2014-02-13       Impact factor: 3.452

4.  Maternal Influenza Vaccination and the Risk of Laboratory-Confirmed Influenza Among Household Contacts Under the Age of Five in Mali.

Authors:  Andrea G Buchwald; Boubou Tamboura; Fadima C Haidara; Flanon Coulibaly; Moussa Doumbia; Fatoumata Diallo; Sarah Boudova; Adama M Keita; Samba O Sow; Karen Kotloff; Myron Levine; Milagritos D Tapia
Journal:  Am J Trop Med Hyg       Date:  2019-01       Impact factor: 2.345

5.  Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study.

Authors:  Andrew C Hayward; Ellen B Fragaszy; Alison Bermingham; Lili Wang; Andrew Copas; W John Edmunds; Neil Ferguson; Nilu Goonetilleke; Gabrielle Harvey; Jana Kovar; Megan S C Lim; Andrew McMichael; Elizabeth R C Millett; Jonathan S Nguyen-Van-Tam; Irwin Nazareth; Richard Pebody; Faiza Tabassum; John M Watson; Fatima B Wurie; Anne M Johnson; Maria Zambon
Journal:  Lancet Respir Med       Date:  2014-03-17       Impact factor: 30.700

6.  Incidence and seroprevalence of seasonal influenza a viruses in Egypt: Results of a community-based cohort study.

Authors:  Mokhtar R Gomaa; Rebecca Badra; Amira S El Rifay; Ahmed Kandeil; Mina N Kamel; Noura M Abo Shama; Rabeh El-Shesheny; Ahmed B Barakat; Mohamed A Ali; Ghazi Kayali
Journal:  Influenza Other Respir Viruses       Date:  2022-02-18       Impact factor: 5.606

7.  2009 A(H1N1) seroconversion rates and risk factors among the general population in Vientiane Capital, Laos.

Authors:  Alexia Kieffer; Phimpha Paboriboune; Pascal Crépey; Bruno Flaissier; Vimalay Souvong; Nicolas Steenkeste; Nicolas Salez; François-Xavier Babin; Christophe Longuet; Fabrice Carrat; Antoine Flahault; Xavier de Lamballerie
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

8.  Molecular evolutionary analysis of pH1N1 2009 influenza virus in Reunion Island, South West Indian Ocean region: a cohort study.

Authors:  Hervé Pascalis; Sarah Temmam; David A Wilkinson; Najla Dsouli; Magali Turpin; Xavier de Lamballerie; Koussay Dellagi
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

9.  Determinants of individuals' risks to 2009 pandemic influenza virus infection at household level amongst Djibouti city residents--a CoPanFlu cross-sectional study.

Authors:  Fred Andayi; Pascal Crepey; Alexia Kieffer; Nicolas Salez; Ammar A Abdo; Fabrice Carrat; Antoine Flahault; Xavier de Lamballerie
Journal:  Virol J       Date:  2014-01-27       Impact factor: 4.099

Review 10.  Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries.

Authors:  Maria D Van Kerkhove; Siddhivinayak Hirve; Artemis Koukounari; Anthony W Mounts
Journal:  Influenza Other Respir Viruses       Date:  2013-01-21       Impact factor: 4.380

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.